论文部分内容阅读
日本的ＳＳ制药／Ｋａｋｅｎ两家公司正联手开发非甾体抗炎药氟比洛芬（ｆｌｕｒｂｉｐｒｏｆｅｎ）的一种新型缓释制剂，该制剂将采用由美国南方研究所（ＳＲＩ）首创和转让的微球释放技术，它可使药物缓释达数周。两家公司称，该制剂可应用于手术后的含氟比洛芬缝合线中。氟
Japan’s SS Pharma / Kaken and the two companies are working together to develop a new sustained-release formulation of the flurbiprofen, a non-steroidal anti-inflammatory drug, that will be based on the first of its kind approved by the South American Research Institute (SRI) Ball release technology, which allows drugs to be released for several weeks. The companies said the formulation can be used in postoperative flurbiprofen seams. fluorine